Adams, J., N., Martelle, S., E., Raffield, L., M., Freedman, B., I., Langefeld, C., D., Hsu, F.-C., … Bowden, D., W. (2016). Analysis of Advanced Glycation End Products in the DHS Mind Study. Journal of Diabetes and its Complications, 30(2), 262–268. Brimelow, R., West, N., Williams, L., Cripps, A., & Cox, A. (2016). A role for whey-derived lactoferrin and immunoglobulins in the attenuation of obesity-related inflammation and disease? Critical reviews in food science and nutrition, 00–00. Grimson, S., Cox, A., Pringle, K., G., Burns, C., Lumbers, E., R., Blackwell, C., C., & Scott, R., J. (2016). The prevalence of unique SNPs in the renin-angiotensin system highlights the need for pharmacogenetics in Indigenous Australians. Clinical and Experimental Pharmacology and Physiology, 43(2), 157–160. Martelle, S., E., Raffield, L., M., Palmer, N., D., Cox, A., Freedman, B., I., Hugenschmidt, C. E., … Bowden, D. (2016). Dopamine pathway gene variants may modulate cognitive performance in the DHS – Mind Study. Brain and Behaviour, 6(4), 1–12. Raffield, L., M., Cox, A., Freedman, B., I., Hugenschmidt, C. E., Hsu, F.-C., Wagner, B. C., … Bowden, D. (2016). Analysis of the relationships between type 2 diabetes status, glycemic control, and neuroimaging measures in the Diabetes Heart Study Mind. Acta Diabetologica, 53(3), 439–447.